Gyre Therapeutics Inc (GYRE) USD0.001

Sell:$6.21Buy:$6.24Price increased$0.10 (1.63%)

Market closed |
Prices delayed by at least 15 minutes
Sell:$6.21
Buy:$6.24
Change:Price increased$0.10 (1.63%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$6.21
Buy:$6.24
Change:Price increased$0.10 (1.63%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
18 June 2026
Weiguo YeCOO
Sell
Option/Award related
3,000$6.35$19,050.00700,000
11 June 2026
Weiguo YeCOO
Sell
Option/Award related
2,800$6.17$17,276.00700,000
10 June 2026
Weiguo YeCOO
Sell
Option/Award related
6,418$6.21$39,855.78700,000
10 June 2026
Weiguo YeCOO
Sell
Option/Award related
5,000$6.24$31,200.00700,000
9 June 2026
Weiguo YeCOO
Sell
Option/Award related
14,500$6.14$89,030.00700,000
9 June 2026
Weiguo YeCOO
Sell
Option/Award related
3,000$6.15$18,450.00700,000
5 June 2026
Weiguo YeCOO
Sell
Option/Award related
15,401$6.40$98,566.40700,000
4 June 2026
Weiguo YeCOO
Sell
Option/Award related
19,575$6.13$119,994.75700,000
26 May 2026
Weiguo YeCOO
Sell
Option/Award related
4,000$6.10$24,400.40700,000
22 May 2026
Weiguo YeCOO
Sell
Option/Award related
3,500$6.08$21,280.00700,000

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
4 June 2026
Weiguo YeCOO
Sell
Option/Award related
19,575$6.13$119,994.75700,000
14 May 2026
Weiguo YeCOO
Sell
Option/Award related
15,580$6.91$107,657.80700,000
5 June 2026
Weiguo YeCOO
Sell
Option/Award related
15,401$6.40$98,566.40700,000
9 June 2026
Weiguo YeCOO
Sell
Option/Award related
14,500$6.14$89,030.00700,000
15 May 2026
Weiguo YeCOO
Sell
Option/Award related
13,100$6.65$87,115.00700,000

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.